<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-14T11:29:45+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>「峰客访谈」沙砾生物创始人刘雅容：TIL疗法有望突破实体瘤细胞治疗现状，A轮融资将用于全面推进一代TIL在中国的临床开发</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/4j4mMWPxK0_wNzDKsHYUbg</id>
    <link href="https://mp.weixin.qq.com/s/4j4mMWPxK0_wNzDKsHYUbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症疫苗联合T细胞疗法，胶质母细胞瘤双重免疫疗法即将启动关键性临床试验丨医麦猛爆料</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/HWkkXLf9086N1lZBBFZzpA</id>
    <link href="https://mp.weixin.qq.com/s/HWkkXLf9086N1lZBBFZzpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO：全球第三款获批上市的GD2抗体公布临床数据，拯救患病儿童丨医麦猛爆料</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/94ENe2gp6Gd8GWGV7hpzFw</id>
    <link href="https://mp.weixin.qq.com/s/94ENe2gp6Gd8GWGV7hpzFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>埃格林医药正式启动中/重度新冠肺炎口服治疗药的临床Ⅰ期试验丨医麦猛爆料</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/il2a7LJYX_tvy4DDw2QoWA</id>
    <link href="https://mp.weixin.qq.com/s/il2a7LJYX_tvy4DDw2QoWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>薛胜利教授：敬畏疾病 感恩患者，不断探究更优的治疗方案</title>
    <updated>2020-12-14T00:19:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/Qeo5vaq_Fi6apZXiHeCuRA</id>
    <link href="https://mp.weixin.qq.com/s/Qeo5vaq_Fi6apZXiHeCuRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T进入加拿大安大略省医保，YESCARTA四年真实世界数据表现卓越丨医麦猛爆料</title>
    <updated>2020-12-13T08:42:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/7rBGYf6fY1SK2fH1lp1C_w</id>
    <link href="https://mp.weixin.qq.com/s/7rBGYf6fY1SK2fH1lp1C_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>VEGFR2单抗联合K药治疗转移性三阴性乳腺癌显示出积极的有效性和安全性丨医麦猛爆料</title>
    <updated>2020-12-13T08:42:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/ztcVG4wCkL0vOyMY8rF1Zg</id>
    <link href="https://mp.weixin.qq.com/s/ztcVG4wCkL0vOyMY8rF1Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DNA治疗性疫苗显示出对HPV阳性相关肛门癌前病变的有效性和安全性丨医麦猛爆料</title>
    <updated>2020-12-13T08:42:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/Ubof49oTdhUnh2xk-kwizg</id>
    <link href="https://mp.weixin.qq.com/s/Ubof49oTdhUnh2xk-kwizg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>黄慧强教授：淋巴瘤PD-1单抗进入PLUS时代，探索更安全高效的联合治疗策略</title>
    <updated>2020-12-13T08:42:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/tYioQvXnB-oWq3Imqt7kgg</id>
    <link href="https://mp.weixin.qq.com/s/tYioQvXnB-oWq3Imqt7kgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science子刊：即将上市的眼科基因疗法发布最新III期研究结果，单侧眼睛治疗意外改善双侧视力丨医麦猛爆料</title>
    <updated>2020-12-12T07:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/P_B8ojYHvDHwmkQXfVnRgg</id>
    <link href="https://mp.weixin.qq.com/s/P_B8ojYHvDHwmkQXfVnRgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>治疗心脏病！AAV基因疗法早期临床数据显示出积极的希望丨医麦猛爆料</title>
    <updated>2020-12-12T07:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/eOXPMXgZsuOI-Xuq0cLAZw</id>
    <link href="https://mp.weixin.qq.com/s/eOXPMXgZsuOI-Xuq0cLAZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」复旦大学生命科学学院院长林鑫华：推动精准医学发展需多学科共同努力</title>
    <updated>2020-12-12T07:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/_M1qiSw5F5hsRkzbncL_RA</id>
    <link href="https://mp.weixin.qq.com/s/_M1qiSw5F5hsRkzbncL_RA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陈文明教授：治疗复发难治MM，多药联合是未来趋势</title>
    <updated>2020-12-12T07:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/D1lBhoPUefOJ4V52QsOEOA</id>
    <link href="https://mp.weixin.qq.com/s/D1lBhoPUefOJ4V52QsOEOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又一款CAR-T被拟纳入突破性治疗品种！这次是合源生物丨医麦猛爆料</title>
    <updated>2020-12-12T07:20:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/o_vZCyaV9tdlc_UYYFtbnw</id>
    <link href="https://mp.weixin.qq.com/s/o_vZCyaV9tdlc_UYYFtbnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内原创基因治疗产品获FDA批准临床，标志着源兴基因病毒载体CDMO服务平台又一成果丨医麦猛爆料</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/R6esBWOIidztmIyp4Ix1Og</id>
    <link href="https://mp.weixin.qq.com/s/R6esBWOIidztmIyp4Ix1Og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨沙砾生物宣布完成1亿元A轮融资，推进TIL疗法在多个实体瘤适应症的临床研究</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/Peku_29PXeBZjD2g_l2rUQ</id>
    <link href="https://mp.weixin.qq.com/s/Peku_29PXeBZjD2g_l2rUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗上市前夕，安全性成为讨论焦点丨医麦新观察</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/5zTyRstwWXQ92AC1GPU65w</id>
    <link href="https://mp.weixin.qq.com/s/5zTyRstwWXQ92AC1GPU65w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首例BCMA CAR-T细胞治疗难治性原发性浆细胞白血病，单细胞转录组测序发现CAR-T细胞增殖和杀伤的特征性过程</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/0QV5QiL0MiZwSiixXgSitg</id>
    <link href="https://mp.weixin.qq.com/s/0QV5QiL0MiZwSiixXgSitg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新：重庆精准生物双靶点CAR-T细胞的IND申请获默示许可，治疗复发/难治性多发性骨髓瘤丨医麦猛爆料</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/N76lbgj1AtwAtifhmQH06A</id>
    <link href="https://mp.weixin.qq.com/s/N76lbgj1AtwAtifhmQH06A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张明智教授：十年探索 不断创新——NKT细胞淋巴瘤治疗经验分享</title>
    <updated>2020-12-11T00:47:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/XO_J1YU6903YwoNiIwy8BA</id>
    <link href="https://mp.weixin.qq.com/s/XO_J1YU6903YwoNiIwy8BA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>